TITLE

Pharma Industry Looks to PLM

PUB. DATE
October 2007
SOURCE
Chem.info;Oct2007, Vol. 45 Issue 10, p74
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article offers information on the report titled "Streamlining Information in the Pharmaceutical Industry with PLM," by Datamonitor, an independent market analysis firm in the U.S. The report figures that the amount to be spent on product lifecycle management (PLM) by the pharmaceutical industry in North America, Europe, China, and Japan will be $460.2 million by the end 2007 and will more than double by 2012.
ACCESSION #
27014777

 

Related Articles

  • The Evolving Pharmaceutical Value Chain Forecasting Growth for Small and Large Molecules. King, Simon // Pharmaceutical Technology;Oct2006 CPhl Supplement, Vol. 30, ps6 

    The article focuses on the analysis of the factors driving demand and how the technology life cycles of Big Pharma and Biologics will affect market potential. The commercialization of small-molecule drugs which refer to drugs with molecular weights became the driving factor for the growth of...

  • Product Life-Cycle Management for Injectable Drugs. Koch, Juergen // Pharmaceutical Technology;Dec2006, Vol. 30 Issue 12, p90 

    The article focuses on the significance of product life-cycle management strategy on manufacturers of injectable drugs. This concept allows the efficient modification and management of a pharmaceutical company on its product throughout its life cycle. It is capable of increasing a company's...

  • Starting the Launch Race Early. Easley, Chris; Manuguid, Fil; Burrows, Nigel; Catley, Linda // European Pharmaceutical Executive;Sep/Oct2005, p44 

    Discusses the importance of starting a pharmaceutical company's product life cycle management strategy sufficiently before launch, and of committing to a proactive and integrated approach. Epidemiology; Expansion of drug indications; Commercial potential.

  • Product life cycle management.  // European Pharmaceutical Executive;Sep/Oct2005, p60 

    Discusses findings of a report, titled "Defending Brand Revenue: Pharmaceutical Lifecycle Management Planning," which examines the facts about produce life cycle management. Benefits of product life cycle management; Finding that over half of pharmaceutical companies polled rate their life cycle...

  • Growing Pains. Smith, Brian D. // European Pharmaceutical Executive;May2007, p36 

    The article focuses on the need to understand the life cycle of the pharmaceutical industry for marketers to optimize their strategies. Particularly, the article addresses the issue of what happens when all the product life cycles in an industry aggregate into an industry life cycle curve. Basic...

  • Total Cost as Suitable Indicator in Realization of More Sustainable Product Life Cycles Regarding Utilization of Natural Abiotic Resources. Carlsson, Bo // Journal of Sustainable Development;2010, Vol. 3 Issue 3, p36 

    A total cost accounting approach was used to analyse the suitability of copper and aluminium as winding material for transformers with respect to sustainability, using available data from the Ecoinvent database. It could be concluded that repeated recycling of metal is a necessary requisite to...

  • Impact of Target Costing and Activity Based Costing on Improving the Profitability of Spinning Mills in Coimbatore - Empirical study on Spinning Mills. Joseph, Jelsy; Vetrivel, A. // Journal of Contemporary Research in Management;Apr-Jun2012, Vol. 7 Issue 2, p41 

    Rapid developments in Technology, change in customer expectations, shortening product life cycles and especially increasing global competition force the companies reach the targets of "low cost, short time and high quality" at the same time and the highest level possible. Therefore, companies...

  • Start Earlier, Sell More, Sell Longer. Daly, Richard; Kolassa, Mick // Pharmaceutical Executive;Mar2003 Supp Handbook, p8 

    Discusses strategies on how pharmaceutical companies can reshape the lifecycle curves of their products in the U.S. market. Anticipation of regulatory risks; Method on how to defend a company's products through legal means; Establishment of critical alliances when weaknesses are identified.

  • Compliance by Design and Compliance Master Plan: Implementing a Materials Quality System. Pluta, Paul L.; Poska, Richard; Fields, Timothy J. // Pharmaceutical Technology;Mar2011, Vol. 35 Issue 3, p90 

    Compliance-by-design methodology comprises a structured approach to quality systems. It identifies objectives, parameters, variables, control of variables, and ongoing monitoring. Information is documented in a compliance master plan. The authors review this approach, which is based on quality...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics